Free Trial

Analysts Set Hinge Health Inc. (NYSE:HNGE) Target Price at $46.00

Hinge Health logo with Services background

Hinge Health Inc. (NYSE:HNGE - Get Free Report) has been assigned an average rating of "Buy" from the thirteen brokerages that are covering the stock, Marketbeat reports. Thirteen analysts have rated the stock with a buy rating. The average 1 year price target among brokers that have issued ratings on the stock in the last year is $46.00.

Several brokerages have recently weighed in on HNGE. Truist Financial began coverage on Hinge Health in a report on Monday. They issued a "buy" rating and a $48.00 price target on the stock. Bank of America began coverage on Hinge Health in a report on Monday. They issued a "buy" rating and a $42.00 price target on the stock. Stifel Nicolaus assumed coverage on Hinge Health in a report on Monday. They issued a "buy" rating and a $48.00 price target on the stock. Morgan Stanley assumed coverage on Hinge Health in a report on Monday. They set an "overweight" rating and a $46.00 price objective on the stock. Finally, Canaccord Genuity Group initiated coverage on Hinge Health in a report on Monday. They set a "buy" rating and a $52.00 price objective on the stock.

Get Our Latest Report on Hinge Health

Hinge Health Trading Up 4.7%

Shares of NYSE HNGE traded up $1.79 during midday trading on Monday, hitting $39.79. The company's stock had a trading volume of 771,425 shares, compared to its average volume of 1,215,089. Hinge Health has a 12-month low of $33.42 and a 12-month high of $43.80.

Hinge Health Company Profile

(Get Free Report

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.

Recommended Stories

Analyst Recommendations for Hinge Health (NYSE:HNGE)

Should You Invest $1,000 in Hinge Health Right Now?

Before you consider Hinge Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hinge Health wasn't on the list.

While Hinge Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Made in America Stocks Under $20 You Need to See!
3 Cheap Growth Stocks Set to Explode This Summer
The Next NVIDIA? Quantum Computing Stocks Set for Explosive Growth

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines